First Manhattan CO Merck & Co., Inc. Transaction History

First Manhattan CO

$31.9 Billion
Q3 2024

A detailed history of First Manhattan CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, First Manhattan CO holds 210,119 shares of MRK stock, worth $21 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

210,119

Previous 210,857 0.35%

Holding current value

$21 Million

Previous $26.1 Million 8.59%

% of portfolio

0.07%

Previous 0.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$111.15 - $128.97 $82,028 - $95,179	-738 Reduced 0.35%	210,119 $23.9 Million
Q2 2024 Aug 13, 2024	BUY	$123.8 - $132.96 $343,668 - $369,096	2,776 Added 1.33%	210,857 $26.1 Million
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $274,607 - $319,978	-2,425 Reduced 1.15%	208,081 $27.5 Million
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $646,060 - $703,069	-6,449 Reduced 2.97%	210,506 $22.9 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $537,296 - $596,688	-5,219 Reduced 2.35%	216,955 $22.3 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $748,214 - $815,519	-6,889 Reduced 3.01%	222,174 $25.6 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $856,563 - $955,750	-8,321 Reduced 3.51%	229,063 $24.4 Million
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $118,830 - $152,357	-1,359 Reduced 0.57%	237,384 $26.3 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $668,716 - $751,228	-7,911 Reduced 3.21%	238,743 $20.6 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $725,110 - $821,948	-8,685 Reduced 3.4%	246,654 $22.5 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $336,087 - $376,732	-4,572 Reduced 1.76%	255,339 $21 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $185,470 - $232,325	-2,566 Reduced 0.98%	259,911 $19.9 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $360,478 - $396,436	-5,029 Reduced 1.88%	262,477 $19.7 Million
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $478,951 - $529,769	6,812 Added 2.61%	267,506 $20.8 Million
Q1 2021 May 14, 2021	BUY	$68.86 - $81.11 $5.88 Million - $6.93 Million	85,415 Added 48.73%	260,694 $20.1 Million
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $92,870 - $103,067	1,294 Added 0.74%	175,279 $14.3 Million
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $360,338 - $408,445	-4,924 Reduced 2.75%	173,985 $14.4 Million
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $376,747 - $428,695	-5,350 Reduced 2.9%	178,909 $13.8 Million
Q1 2020 May 06, 2020	BUY	$63.36 - $87.82 $25,280 - $35,040	399 Added 0.22%	184,259 $14.2 Million
Q4 2019 Feb 13, 2020	BUY	$77.58 - $87.54 $312,259 - $352,348	4,025 Added 2.24%	183,860 $16.7 Million
Q3 2019 Nov 13, 2019	SELL	$76.08 - $82.93 $845,857 - $922,015	-11,118 Reduced 5.82%	179,835 $15.1 Million
Q2 2019 Aug 16, 2019	BUY	$69.84 - $81.59 $251,424 - $293,724	3,600 Added 1.92%	190,953 $16 Million
Q1 2019 Apr 12, 2019	SELL	$69.58 - $79.36 $659,548 - $752,253	-9,479 Reduced 4.82%	187,353 $15.6 Million
Q4 2018 Jan 30, 2019	SELL	$65.24 - $75.71 $205,701 - $238,713	-3,153 Reduced 1.58%	196,832 $15 Million
Q3 2018 Oct 15, 2018	SELL	$57.69 - $67.84 $237,798 - $279,636	-4,122 Reduced 2.02%	199,985 $14.2 Million
Q2 2018 Aug 01, 2018	SELL	$50.83 - $59.72 $465,958 - $547,453	-9,167 Reduced 4.3%	204,107 $12.4 Million
Q1 2018 Apr 20, 2018	SELL	$50.96 - $59.23 $344,897 - $400,868	-6,768 Reduced 3.08%	213,274 $11.6 Million
Q4 2017 Jan 22, 2018	SELL	$51.62 - $61.64 $591,565 - $706,394	-11,460 Reduced 4.95%	220,042 $12.4 Million
Q3 2017 Oct 25, 2017	BUY	$58.67 - $63.13 $13.6 Million - $14.6 Million	231,502	231,502 $14.8 Million

Others Institutions Holding MRK

# of Institutions

3,826

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.

Account

First Manhattan CO Merck & Co., Inc. Transaction History